{"id":"NCT01392573","sponsor":"Novo Nordisk A/S","briefTitle":"A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes","officialTitle":"A 26-week Randomised, Parallel Two-arm, Double-blind, Multi-centre, Multinational, Treat-to-target Trial Comparing Fixed Ratio Combination of Insulin Degludec and Liraglutide With Insulin Degludec in Subjects With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11-28","primaryCompletion":"2012-10-01","completion":"2012-10-04","firstPosted":"2011-07-12","resultsPosted":"2017-01-20","lastUpdate":"2019-01-03"},"enrollment":413,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec/liraglutide","otherNames":[]},{"type":"DRUG","name":"insulin degludec","otherNames":[]}],"arms":[{"label":"IDegLira + metformin","type":"EXPERIMENTAL"},{"label":"IDeg + metformin","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Asia, Europe and the United States of America (USA). The aim of this trial is to compare the efficacy and safety of insulin degludec/liraglutide (IDegLira) and insulin degludec (IDeg) in subjects with type 2 diabetes. Subjects continue their pre-trial treatment with metformin throughout the entire trial.","primaryOutcome":{"measure":"Change From Baseline in HbA1c (Glycosylated Haemoglobin)","timeFrame":"Week 0, week 26","effectByArm":[{"arm":"IDegLira","deltaMin":-1.9,"sd":1.09},{"arm":"IDeg","deltaMin":-0.89,"sd":1.18}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":9},"locations":{"siteCount":86,"countries":["United States","Bulgaria","Denmark","Hungary","India","Slovenia","Switzerland"]},"refs":{"pmids":["28332144","28063135","25114296","26894800","28282219","30383495","39963952"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":199},"commonTop":["Diarrhoea","Nausea","Lipase increased","Nasopharyngitis","Headache"]}}